Minimizing the role of cryoprotectant toxicity for cryopreservation
Minimizing the role of cryoprotectant toxicity for cryopreservation
批准号:
8890272
负责人:
Utkan Demirci
金额:
$5.6万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2016-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Long-term biopreservation of cells and tissues has a broad impact in multiple fields including tissue engineering, regenerative medicine, stem cells, blood banking, animal strain preservation (biodiversity protection), clinical sample storage, transplantation medicine and in vitro drug testing. Vitrification (ice/crystal-free cryopreservatio) has emerged as a novel approach over traditional slow freezing methods. Although vitrification minimizes mechanical damage due to ice crystal nucleation, it suffers from toxicity due to high concentrations of cryoprotectant agents (CPAs). The current vitrification methods require extremely high levels of CPAs of up to 8.2 M that are cytotoxic and cause osmotic shock. Also, the lengthy manual processing steps of current vitrification methods add to the technical complexity, require highly trained technicians, and result in variations between users. For instance, low CPA-level vitrification has immense potential for the stem cells compared to other methods in preserving their functionality. Recently, we demonstrated that we can achieve vitrification at ultra-rapid freezing and thawing rates with as low as 1.5M CPA concentration. We are adapting this new knowledge to the vital needs of cell cryopreservation at the clinic including
discarded anonymous human oocytes. This proposal investigates a new experimental strategy to minimize the CPA concentrations and improve clinical outcomes using novel technologies (i.e., nanoliter droplet vitrification). These steps are facilitated by theoretical understanding o the underlying mechanisms governing vitrification. The expected outcome of this study is a closed-system platform technology with broad applications to human cell (e.g., hepatocytes, oocytes, sperm, stem cells), tissues (e.g., blood), micro-tissues (e.g., embryoid bodies, islets) covering areas of reproductive medicine, tissue engineering and regenerative medicine as well as to wild life preservation. These studies can also significantly impact the care of infertile couples and facilitate fertility preservation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NOVEL EXOSOME BIOMARKERS OF IRON PATHOLOGY IN AD
-
批准号:10223789
-
项目类别:
-
资助金额:$43.3万
-
财政年份:2021
-
负责人:Utkan Demirci
-
依托单位:
CANARY CANCER RESEARCH EDUCATION SUMMER TRAINING (CANARY CREST) PROGRAM
-
批准号:10462468
-
项目类别:
-
资助金额:$23.67万
-
财政年份:2017
-
负责人:Utkan Demirci
-
依托单位:
CANARY CANCER RESEARCH EDUCATION SUMMER TRAINING (CANARY CREST) PROGRAM
-
批准号:10713237
-
项目类别:
-
资助金额:$41.86万
-
财政年份:2017
-
负责人:Utkan Demirci
-
依托单位:
CANARY CANCER RESEARCH EDUCATION SUMMER TRAINING (CANARY CREST) PROGRAM
-
批准号:9358372
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2017
-
负责人:Utkan Demirci
-
依托单位:
CANARY CANCER RESEARCH EDUCATION SUMMER TRAINING (CANARY CREST) PROGRAM
-
批准号:9762061
-
项目类别:
-
资助金额:$23.67万
-
财政年份:2017
-
负责人:Utkan Demirci
-
依托单位:
CANARY CANCER RESEARCH EDUCATION SUMMER TRAINING (CANARY CREST) PROGRAM
-
批准号:9995434
-
项目类别:
-
资助金额:$19.78万
-
财政年份:2017
-
负责人:Utkan Demirci
-
依托单位:
Single Cell Characterization of Latent HIV-1 Reservoirs
-
批准号:9324120
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2016
-
负责人:Utkan Demirci
-
依托单位:
A Novel Microfluidic HIV-1 Co-Culture Assay to Quantify Latent Reservoirs
-
批准号:8768888
-
项目类别:
-
资助金额:$22.62万
-
财政年份:2014
-
负责人:Utkan Demirci
-
依托单位:
Microfluidic PCR Method to Identify and Characterize HIV-Infected Single Cells
-
批准号:8790281
-
项目类别:
-
资助金额:$22.62万
-
财政年份:2014
-
负责人:Utkan Demirci
-
依托单位:
Novel disposable microchips for HIV-1 viral load
-
批准号:8943940
-
项目类别:
-
资助金额:$41.64万
-
财政年份:2012
-
负责人:Utkan Demirci
-
依托单位:
Minimizing the role of cryoprotectant toxicity for cryopreservation
-
批准号:8925076
-
项目类别:
-
资助金额:$38.94万
-
财政年份:2012
-
负责人:Utkan Demirci
-
依托单位:
Minimizing the role of cryoprotectant toxicity for cryopreservation
-
批准号:8387929
-
项目类别:
-
资助金额:$39.74万
-
财政年份:2012
-
负责人:Utkan Demirci
-
依托单位:
Novel disposable microchips for HIV-1 viral load
-
批准号:8411025
-
项目类别:
-
资助金额:$44.63万
-
财政年份:2012
-
负责人:Utkan Demirci
-
依托单位:
Minimizing the role of cryoprotectant toxicity for cryopreservation
-
批准号:8516040
-
项目类别:
-
资助金额:$31.88万
-
财政年份:2012
-
负责人:Utkan Demirci
-
依托单位:
Minimizing the role of cryoprotectant toxicity for cryopreservation
-
批准号:8686838
-
项目类别:
-
资助金额:$38.55万
-
财政年份:2012
-
负责人:Utkan Demirci
-
依托单位:
Novel disposable microchips for HIV-1 viral load
-
批准号:8508178
-
项目类别:
-
资助金额:$41.95万
-
财政年份:2012
-
负责人:Utkan Demirci
-
依托单位:
Novel disposable microchips for HIV-1 viral load
-
批准号:8681305
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Utkan Demirci
-
依托单位:
Microfluidic Chip for Cryopreservation of Blood Cells
-
批准号:8191888
-
项目类别:
-
资助金额:$26.76万
-
财政年份:2011
-
负责人:Utkan Demirci
-
依托单位:
Microfluidic Chip for Cryopreservation of Blood Cells
-
批准号:8280375
-
项目类别:
-
资助金额:$22.31万
-
财政年份:2011
-
负责人:Utkan Demirci
-
依托单位:
Antibody-based cell purification at resource limited setting for HIV
-
批准号:8024526
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2010
-
负责人:Utkan Demirci
-
依托单位:
国内基金
海外基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
Sestrin2抑制内质网应激对早产儿视网膜病变的调控作用及其机制研究
-
批准号:82371070
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵培泉
-
依托单位: